Stakeholders |
Knowledge synthesis |
Evidence-based recommendation development |
Translation research |
Translation programs |
Academia and Research Institutions |
- Conduct evidence-based reviews
- Develop knowledge bases
|
- Participate in independent panels [Evaluation of Genomic Applications in Practice and Prevention (EGAPP) and the U.S. Preventive Services Task Force (USPSTF)]
|
- Join and organize research groups
- Conduct translation research
|
- Serve on translation advisory committees
- Conduct outcomes research
|
Government |
- Conduct and provide funding for evidence-based reviews (federal)
- Develop and provide funding for establishing knowledge bases (federal)
- Generate and synthesize population-based data (federal and state)
- Convene scientific community (federal and state)
|
- Support the development of methods and processes for establishing evidence-based recommendations (federal)
- Provide funding for the development of evidence-based recommendations (federal)
|
- Provide funding for translation research (federal)
- Create partner collaborations through funding opportunities (federal)
|
- Provide funding for translation activities and interventions (federal)
- Conduct translation activities and implement interventions (federal and state)
- Integrate evidence-based reviews and recommendations into Medicare, Medicaid, health insurance plans, and other groups
- Establish educational activities and support policy interventions (e.g., to promote the appropriate use of genomics applications, protect against misuse of genetic information, protect against harm due to genetic test results)
- Generate and synthesize population-based data
- Establish diverse partnerships and multidisciplinary advisory committees
|
Health Plans |
- Commission and conduct evidence-based reviews
|
- Participate in independent panels [Evaluation of Genomic Applications in Practice and Prevention (EGAPP) and the U.S. Preventive Services Task Force (USPSTF)]
|
|
- Establish reimbursement policies for the use of genomic applications based on evidence-based reviews and recommendations
- Develop and disseminate translated educational materials (e.g., to promote the appropriate use of genomics applications, protect against misuse of genetic information, protect against harm due to genetic test results)
|
Industry |
|
|
- Conduct translation research
|
- Develop new technologies, chips, informatics, etc.
|
Professional and Advisory Organizations |
- Commission and conduct evidence-based reviews (EGAPP and USPSTF)
|
- Develop methods and processes for establishing evidence-based recommendations (EGAPP and USPSTF)
- Develop evidence-based recommendations (EGAPP and USPSTF)
|
|
- Implement genomic applications through professional engagement, continuing medical education credits, and other educational activities
- Develop policy statements and recommendations for the use of genomics applications in clinical and public health practice
|
Community and Consumer Groups |
|
|
- Participate in community-driven translation research
|
- Conduct translation activities and interventions
- Advocate for policies on appropriate use of genomic applications
- Establish diverse partnerships and multidisciplinary advisory committees
|
Patient Advocacy Groups |
|
|
|
- Provide and disseminate evidence-based materials through Web sites and other media for patients and their families
- Host patient education seminars
|